chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In late Feb2021 I started to develop symptoms which increased substantially in March and April was diagnosed with Long Haul reaction; In late Feb2021 I started to develop symptoms which increased substantially in March and April was diagnosed with Long Haul reaction; This is a spontaneous report from a contactable consumer (patient). A 76-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 02Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE, and dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation, age at vaccination was unknown. The patient medical history and concomitant medications were not reported. In late Feb2021, patient started to develop symptoms which increased substantially in March and April and was diagnosed with Long Haul reaction in late March which patient stated are now presenting a significant problem. Patient wanted to know if there is a blood test available to verify this diagnose. Patient stated he is also interested in knowing and obtaining any medication to cure this problem. Treatment was not received. Patient was not on medication and no other treatments going on. He stated he has no idea what to do. Outcome of the events was unknown.  Information on the Batch/Lot number has been requested.
Joint pain; swelling; This case was reported by a consumer via interactive digital media and described the occurrence of joint pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 5 weeks after receiving Shingrix, the patient experienced joint pain and swelling. On an unknown date, the outcome of the joint pain and swelling were unknown.   It was unknown if the reporter considered the joint pain and swelling to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrix, the patient experienced joint pain and swelling.
When injection was removed from site and bandage. Immediately the site started swelling into a bump or circular shape. Medical assistant called LVN and the nurse had looked at the site and asked patient if feeling well. Nurse called Dr. to inspect the site and asked for if patient was feeling well, and asked of medication taken. Patient stated not feeling any other symptoms and that he just felt a small discomfort on the injection site. Doctor recommend to place a ice pack on the site, which was given to the patient by nurse. Patient was advise to keep observation for any unusual or symptoms  on the site and contact the clinic immediately.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 2:14 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 2:14 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 74.02. No concomitant medications were reported. Batch number 041L20A administered on 11-Jan-2021 underwent temperature excursion with temperature range of 35 degrees Fahrenheit at 02:00 PM. This vial was moved to fridge on 08-Jan-2021 and beyond use date for the vial was reported as 07-Feb-2021. Product moved to clinic on 11-Jan-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue) and PYREXIA (Fever). At the time of the report, FATIGUE (Fatigue) and PYREXIA (Fever) had resolved.            It was reported that patient had no known allergies. Patient had no acute illnesses at the time of vaccination and up to one month before. Patient had no chronic or long-standing health conditions. It was reported that patient was not diagnosed/tested positive for COVID-19. No concomitant medication reported. No treatment medication reported.   This case was linked to MOD-2022-455450 (Patient Link).
Tingling sensation all over body; felt numb/weird sensation in arms and legs/foot felt numb/numbness in left leg/numbness in left arm/numbness in right side of face (cheek and tongue); Rash all over body; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation all over body), HYPOAESTHESIA (felt numb/weird sensation in arms and legs/foot felt numb/numbness in left leg/numbness in left arm/numbness in right side of face (cheek and tongue)) and RASH (Rash all over body) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 22-Jun-2022. On 30-Mar-2021, the patient experienced PARAESTHESIA (Tingling sensation all over body) and RASH (Rash all over body). 30-Mar-2021, the patient experienced HYPOAESTHESIA (felt numb/weird sensation in arms and legs/foot felt numb/numbness in left leg/numbness in left arm/numbness in right side of face (cheek and tongue)). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Tingling sensation all over body), HYPOAESTHESIA (felt numb/weird sensation in arms and legs/foot felt numb/numbness in left leg/numbness in left arm/numbness in right side of face (cheek and tongue)) and RASH (Rash all over body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication were provided On 30-Mar-2021 the symptoms started and went on and off for three months. Post that patient recovered; however, afraid of getting Moderna Vaccine. Patient had last menstrual period on 18Sep2021.
I started with hives all over my back, buttocks, arms and legs early Thursday morning. They got worse Friday and still all weekend I?m finding more hives show up. I?m taking Benadryl around the clock and using hydrocortisone cream.
at the time of injection, a sharp pain went from my neck down to my hand, it lasted about a minute
Initial information received on 16-Jan-2019 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 69 years old male patient who received vaccine MENACTRA. The patient's past medical history and family history were not provided. The patient did not receive any concomitant medication. On 15-Jan-2019, the patient received a 0.5ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U5746AC, expiry date 14-Oct-2018 via intramuscular route in the left deltoid. It was an actual medication error due to expired vaccine used. It was reported that patient was given an expired dose (expiry date 14-Oct-2018) of MENACTRA vaccine on 15-Jan-2019. It was unknown whether patient experienced any adverse reaction after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Mild, Systemic: dry mouth and nose. had a nose bleed 10 mins after vaccination, stopped with pressure-Severe, Systemic: Nausea-Medium, Systemic: Shakiness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild
Information has been received from a physician concerning a 12 year old male patient who was vaccinated with the first and second dose of MMR II respectively on 16-FEB-1999 and on 06-FEB-2002. On 15-NOV-2009 the patient developed afebrile mumps and stomach ache. The patient was diagnosed on 14-DEC-2009. The patient's fever count was 65 and his parotitis was on left side; count 81. On 14-DEC-2009 the patient's serum immunoglobulin G (IgG) was 10.07 and serum amylase was 73. The outcome of the patient was not reported. Follow-up information was received which reported that on 21-JAN-2010, the patient developed right parotitis with swelling under right ear. There was no other symptom. It was diagnosed on 22-JAN-2010. On 22-JAN-2010, the patient's serum immunoglobulin G (IgG) was 6.9 and serum amylase was 131. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information is not expected.
Delayed Rash on back of upper arms, upper back and upper thighs and all over body itching.
Child given 0.25 ml dose influenza instead of 0.5 ml dose - correct influenza vaccine given before family left - error noted immediately and explained to mother.
Diagnosed with pericarditis.  Intermittent chest pain and a change in my EKG morphology led me to go get seen by a cardiologist.
Redness, swelling, heat at site, upper lip swelling. Tx: ZYRTEC; ibuprofen; return as needed.
CRAMPS IN LEGS/MUSCLE STRETCH; SLUGGISHNESS; INJECTION SITE BRUISING; CHILLS; PAIN IN ARM/LEG PAIN; FELT VERY TIRED; HEADACHE; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: UNKNOWN) dose was not reported, administered on 18-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced cramps in legs/muscle stretch, sluggishness, injection site bruising, chills, pain in arm/leg pain, felt very tired, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sluggishness, chills, and felt very tired, and had not recovered from cramps in legs/muscle stretch, pain in arm/leg pain, injection site bruising, and headache. This report was non-serious.
Sudden onset of symptoms; Sudden onset of facial asymmetry, not able to smile properly; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Sudden onset of symptoms) and FACIAL ASYMMETRY (Sudden onset of facial asymmetry, not able to smile properly) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018F21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Patient first 2 doses were Pfizer.). Past adverse reactions to the above products included No adverse event with Pfizer.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced VACCINATION COMPLICATION (Sudden onset of symptoms) and FACIAL ASYMMETRY (Sudden onset of facial asymmetry, not able to smile properly). At the time of the report, VACCINATION COMPLICATION (Sudden onset of symptoms) and FACIAL ASYMMETRY (Sudden onset of facial asymmetry, not able to smile properly) outcome was unknown.            Concomitant medications was not provided by the reporter. Treatment information was not provided.  A week after the booster shot of Moderna vaccine , she felt sudden onset of symptoms where she was not able to smile properly, she does not know if it was Bell's Palsy.
Tingling in left arm & pain, 2 out of 10 & weakness. Reports normal grip but slight weakness noted. Tingling in left side of face and left scalp. No impairment in lower extrem- ities or noted inability to perform usual activities or job.  Had similar symptom following flu vaccine in 2019. Symptoms started around 2 weeks following vaccine. Did not realize symptoms could be related to vaccine. Saw physicians for eval and treatment,  including physical therapy. Symptoms lasted about 3 months  before resolution. Was hospitalized twice due to concerns that vaccine reaction was not considered due to the delay in onset of symptoms, vaccinated on 10/7/19 and symptoms onset 10/26/19. Vaccine in 2019 = Fluzone Quad, lot # UT6647MA, exp 6/29/20. Given in (L) deltoid in 2019.
Sore throat; Upset stomach; Chills; Severe headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), ABDOMINAL DISCOMFORT (Upset stomach), CHILLS (Chills), HEADACHE (Severe headache) and FATIGUE (Fatigue) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), ABDOMINAL DISCOMFORT (Upset stomach), CHILLS (Chills), HEADACHE (Severe headache) and FATIGUE (Fatigue). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), ABDOMINAL DISCOMFORT (Upset stomach), CHILLS (Chills), HEADACHE (Severe headache) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Chills, body aches, fever, headache, chest pain, pain when breathing, abdominal pain, muscle pain
Client complained of dizziness 5 min after first dose of Pfizer.  Placed in zero gravity chair, water given to drink, vital signs stable.  Continued monitoring vital signs, dizziness resolved @ 1:10 pm, able to walk out @ 1:15pm with her mother.
Lethargy, visual disturbances, dizziness, weakness, cold, clammy, profuse perspiration. Pharmacist called 911/EMS.
When I woke up the morning following my shot in my left arm, my left leg, from the bottom of my knee down to the top of my foot, was numb. This continued for several weeks and is still somewhat present to this day. It never "hurt", but just felt numb to the touch. I was able to walk and do normal activities, but when resting or sitting/laying, it was very uncomfortable. Now, almost 6 weeks out, it has slowly started to go away, but can still feel the "numbness" from time to time.
Patient received fluarix approximately 8am (reported no previous reaction to flu vaccine in the past), around 8:30am experienced flushing of face, neck, chest and became diaphoretic, symptoms lasted about 30 min then resolved, still felt hot but no longer flushed or sweating.  At 11am patient took a cetirizine tablet and ibuprofen.  Around 11:30am her symptoms returned with the addition of headache and developing of tightness of the throat.  At around 12:15pm patient was admitted to the ER she felt as though her throat was starting to close up and throat felt scratchy, she was examined and her airway was clear and she was able to swallow medications by mouth.  At 12:32pm prednisone 50mg and diphenhydramine 50mg were given.  Continued to feel like throat was closing, epipen 0.3mg administered about 2pm, ER continued to observe patient, around 2:20pm patient was feeling better, throat no longer swollen or scratchy, no longer felt flushed.  Patient is still being observed in the ER as I writing up this report at about 3:30 pm
ringing of the ears. onset of tinnitis throug out the day on day 3 after vaccination
She got her vaccine, she had fever highest was 101.2, tiredness, bad headache, upset stomach, minimal muscle pain.   She took nothing for the symptoms, afraid of messing up the vaccine.  She did not call her doctor.   She is feeling better, no fever, and feeling much better, no pain, the head is not hurting and up and about.
Patient began to feel confused and dizzy after receiving the vaccine and had gait ataxia. Patient states that she saw her dog run out the door of her home and she attempted to get him and fell down 6 flights of steps. Patient states that she landed on her back  and hit her head on the ground yesterday. Patient was able to crawl into her house. Patient also c/o: headache, bilateral knee pain( L>R).  acute HA, rhabdomyolysis
Patient given mmr, var and flu vaccine on 10/19/2016. On 10/21/2016 patient reported she is 8 weeks pregnant.
At the time of injection she was alert & oriented around 1 pm she returned starting to feel hot with noticable redness around face, hands, knees, and elbows, also reports feeling of itchiness. Notified of occurring incident were RN, DON and another. Employee stated she would go to a emergency walk in clinic. Employee was looked completely over, assessed locations for redness, hives, warmth, no first aid measures taken by myself or any other employee at this time. Employee sought care from a walk in clinic.
3/23/03 Noted redness / some soreness very small red area. 3/25 presented w/redness. moderate heat induration at inject site 5 cm to 6.5 increased. No axillary nodes, no fever. Parent had applied Sweden Bitter (herb mixture) to arm overnight.
Left arm lemon size red area started just after injection - progressed bigger until today has area of redness and induration 130mm x 130mm with blister in center 8mm x 5mm. Warmth at site. No fever or illness. No problems noted at right arm.
Swollen, painful knees, discomfort in ankles and wrists.  Started 24 hours after injections and lasted 10 days.
Information has been received from a physician concerning a 14 year old female who on 11-JAN-2008 was vaccinated with a first dose of GARDASIL (lot# 659653/1448U) injection in her left hip. On approximately 15-JAN-2008 "4 days post vaccination" the patient developed "lymphadenitis" along with tenderness in her left groin and fatigue. The patient returned to the physician's office on 21-JAN-2008 and again on 24-JAN-2008 and was referred to a general surgeon for the enlarged lymphnode. On an unspecified date the patient had surgery to remove the lymph node. On an unspecified date blood work and a mononucleosis test was performed. The results were unknown. It was unknown as to whether or not the patient will receive the second and third doses of the vaccine. Further information was not provided regarding this adverse experience. The physician felt that the enlarged lymphnode, tenderness in her left groin area and fatigue were other medical events (OME). Additional information has been requested.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/13/2021. Patient presented to the emergency department with complaints of shortness of breath and admitted for COVID pneumonia. Patient progressed to respiratory failure requiring intubation on 9/16/2021. Despite lung protective mechanical ventilation, paralysis, proning, inhaled pulmonary vasodilators, steroids, broad spectrum antibiotics, and remdesivir, her respiratory failure progressively worsened. On 9/25/2021 patient developed acute renal failure with worsening shock.  Family elected to pursue comfort care at that time. Patient was extubated on 9/25/2021, and expired at 2107 on 9/25/2021.
Broke out in hives on front of neck. Over several days hives spread to back of neck, upper arm, abdomen and butt.  Severe redness and itching. Initial treatment prescribed  6/27/22 Triamcinolone 0.1% cream, apply 3x day for 1-2 weeks.  Rash continued to spread so Dr called in Prednisone 10mg tablet tapering down for 12 days(?) beginning 6/29/22.  Also taking zyrtec during the day and benadryl tablets at night.
10 min post vax, pt devel severe congestion, coughing, and watery eyes, 28rpm, meds given & pt vomited; pos urticaria & wheezing; pox 88 %-o2 @ 8 1/min, pox rose to 95%-moving air & pink-pt recv 3 nebulizer tx but unable to wean o2;